CBO says Grassley-Wyden drug bill would save more than $94 billion in 1st decade
from Healthcare Dive
The Congressional Budget Office estimates the Senate's bipartisan Prescription Drug Pricing Reduction Act could save more than $94 billion over the next decade. The bill would impose some stringent price reporting controls on the pharmaceutical sector, as well as continuing some significant rebates from drug manufacturers. Along with the overall cost savings, the CBO report estimates that Medicare Part D premiums paid by enrollees would drop about $1 billion between 2021 and 2030, even though the enrollee's share of the Part D premium would increase about 4%. However, the pharmaceutical sector mostly remains opposed to the bill.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063